You are here:

Abacavir 300mg tablets (Ziagen®)


Following an abbreviated submission

Abacavir tablets 300mg are accepted for use in a once-daily dosing regimen in NHS Scotland for treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infected adults and adolescents over 12 years, in combination with other antiretroviral medicinal products.

Drug Details

Drug Name: Abacavir 300mg tablets (Ziagen®)
SMC Drug ID: 174/05
Manufacturer: GlaxoSmithKline UK Ltd
Indication: HIV-1
BNF Category:
Sub Category: 5.3 Antiviral Drugs
Submission Type: Abbreviated Submission
Status: Accepted
Date Advice Published: 9 May 2005